Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Thijs J W van de Laar"'
Autor:
Thijs J W van de Laar, Marijke W.A. Molenaar-de Backer, Tanneke Marijt-van der Kreek, Boris M. Hogema, Hans L. Zaaijer
Publikováno v:
Transfusion, 61(7), 2116-2124. Wiley-Blackwell
Background: In the Netherlands, blood donor screening for hepatitis B virus (HBV) consists of HBsAg screening since the 1970s, HBV DNA minipool testing (MP-NAT) since 2008, and anti-HBc screening since 2011. Anti-HBc reactivity causes deferral only i
Autor:
Ard van Sighem, Thijs J W van de Laar, Giovani Vandewalle, Hans L. Zaaijer, Eric C. J. Claas, Eric Van Wijngaerden, Veerle Compernolle, Daniela Bezemer, Anne-Mieke Vandamme, Annie de Smet, Kristel Van Laethem
Publikováno v:
Transfusion. 57:1235-1247
BACKGROUND Separate transmission networks for human immunodeficiency virus (HIV) coexist. Molecular typing of viral genomes can provide insight in HIV transmission routes in donors for whom risk behavior–based donor selection failed. STUDY DESIGN A
Autor:
Mirjam de Waal, Hans L. Zaaijer, Michel Molier, Marijke W.A. Molenaar-de Backer, Thijs J W van de Laar, Boris M. Hogema, Margret Sjerps, Peter van Swieten
Publikováno v:
Transfusion. 56:722-728
BACKGROUND The incidence of hepatitis E virus (HEV) infection in the Netherlands is high. Blood donors are not routinely screened for HEV infection, but since January 2013, donations used for the production of solvent/detergent (S/D)-treated plasma h
Autor:
Thijs J W van de Laar, Mart P. Janssen, Hans L. Zaaijer, Ed Slot, Tanneke Marijt-van der Kreek
Publikováno v:
Transfusion. 56:203-214
BACKGROUND Risk behavior-based donor selection procedures are widely used to mitigate the risk of transfusion-transmissible infections (TTIs), but their effectiveness is disputed in countries with low residual risks of TTIs. STUDY DESIGN AND METHODS
Autor:
Marijke W.A. Molenaar-de Backer, Hans L. Zaaijer, Tanneke Marijt-van der Kreek, Thijs J W van de Laar, Boris M. Hogema
Publikováno v:
Transfusion. 55:1206-1213
Background In the Netherlands, universal antibody to hepatitis B core antigen (anti-HBc) donor screening was introduced in July 2011 to intercept potentially infectious donations slipping through hepatitis B surface antigen (HBsAg) and hepatitis B vi
Autor:
H. Theo M. Cuijpers, Thijs J W van de Laar, Cees L. van der Poel, Marco H.G.M. Koppelman, Akke K. Van der Bij, Roel A. Coutinho, Sylvia M. Bruisten, Hans L. Zaaijer
Publikováno v:
Transfusion. 46:1719-1728
BACKGROUND: To improve transfusion policy and to increase understanding of the spread of hepatitis C virus (HCV) in the general population, HCV infections among voluntary Dutch blood donors were examined with molecular epidemiologic techniques. STUDY
Publikováno v:
Transfusion. 55(2)
Infectious window period donations slip through routine donor screening procedures. To explore the potential value of predonation screening of candidate donors, we compared the proportion of incident transfusion-transmissible infections in candidate
Autor:
Thijs J W, van de Laar, Marco H G M, Koppelman, Akke K, van der Bij, Hans L, Zaaijer, H Theo M, Cuijpers, Cees L, van der Poel, Roel A, Coutinho, Sylvia M, Bruisten
Publikováno v:
Transfusion. 46(10)
To improve transfusion policy and to increase understanding of the spread of hepatitis C virus (HCV) in the general population, HCV infections among voluntary Dutch blood donors were examined with molecular epidemiologic techniques.During 6 years, 19